Maria JoseSoler SpainHospital del Vall d´Hebron

MD, PhD. Head of Clinical Nephrology and Dialysis Unit Nephrology Department. Hospital Universitari Vall d´Hebron. Research lab group leader, Vall d'Hebron Research Institute (VHIR). Vice-presidente Junta Directiva Sociedad Española Nefrología. Co-Chair of the ISN Western Europe Regional Board.

First name

Maria Jose

Upload Picture

https://storage.unitedwebnetwork.com/files/1099/3d2806f350d6b5c0f6132096757f74cc.jpg

Last name

Soler

Institution

Country

Spain

Friday, February 7, 2025

Time	Session

14:15 15:45	Unraveling the Cardiovascular-Kidney-Metabolic Nexus: Making All Work Together for Kidney Care IK02 Parminder KaurJudge Chair parminder.judge@ndph.ox.ac.ukUnited KingdomUniversity of Oxford, UK VineetBehera Chair beheravineet@gmail.comIndiaConsultant Nephrologist & Professor Medicine, INHS Kalyani, Visakhapatnam Cardiovascular-Kidney-Metabolic Syndrome: What Does it Mean? IK02-01 KatherineTuttle Speaker United StatesUniversity of Washington School of Medicine, Division of Nephrology GLP-1 RA in Kidney Disease: Beyond T2DM Control IK02-02 BeatrizFernandez-Fernandez Speaker SpainHospital Universitario Fundación Jimenez Díaz New Frontiers in CKD Therapy: Endothelin Receptor Antagonists IK02-03 Maria JoseSoler Speaker mjsoler01@gmail.comSpainHospital del Vall d´Hebron Myocardial Infarction in Kidney Disease - What Should a Nephrologist Know? IK02-04 Sydney Tang Speaker Hong Kong, ChinaThe University of Hong Kong Q&A IK02-05 Amaltas Hall B101-B

Time

Session

14:15

15:45

Unraveling the Cardiovascular-Kidney-Metabolic Nexus: Making All Work Together for Kidney Care

IK02

Parminder KaurJudge Chair parminder.judge@ndph.ox.ac.ukUnited KingdomUniversity of Oxford, UK

VineetBehera Chair beheravineet@gmail.comIndiaConsultant Nephrologist & Professor Medicine, INHS Kalyani, Visakhapatnam

Cardiovascular-Kidney-Metabolic Syndrome: What Does it Mean?

IK02-01

KatherineTuttle Speaker United StatesUniversity of Washington School of Medicine, Division of Nephrology
GLP-1 RA in Kidney Disease: Beyond T2DM Control

IK02-02

BeatrizFernandez-Fernandez Speaker SpainHospital Universitario Fundación Jimenez Díaz
New Frontiers in CKD Therapy: Endothelin Receptor Antagonists

IK02-03

Maria JoseSoler Speaker mjsoler01@gmail.comSpainHospital del Vall d´Hebron
Myocardial Infarction in Kidney Disease - What Should a Nephrologist Know?

IK02-04

Sydney Tang Speaker Hong Kong, ChinaThe University of Hong Kong
Q&A

IK02-05

Amaltas Hall B101-B